SML1072
GSK-LSD1
≥98% (HPLC), lysine specific demethylase 1 (LSD1) inhibitor, powder
别名:
GSK-LSD1（反式外消旋） 二盐酸盐, rel-N-[（1R，2S）-2-苯基环丙基] -4-哌啶胺盐酸盐（1：2）
登录 查看公司和协议定价
选择尺寸
关于此项目
经验公式（希尔记法）:
C14H20N2 · 2HCl
化学文摘社编号:
分子量:
289.24
UNSPSC代码:
51111800
PubChem化学物质编号:
NACRES:
NA.77
产品名称
GSK-LSD1, ≥98% (HPLC)
质量水平
方案
≥98% (HPLC)
表单
powder
颜色
white to beige
溶解性
H2O: 20 mg/mL, clear
储存温度
2-8°C
SMILES字符串
C1(N[C@@H]2C[C@H]2C3=CC=CC=C3)CCNCC1
InChI
1S/C14H20N2/c1-2-4-11(5-3-1)13-10-14(13)16-12-6-8-15-9-7-12/h1-5,12-16H,6-10H2/t13-,14+/m0/s1
InChI key
BASFYRLYJAZPPL-UONOGXRCSA-N
应用
GSK-LSD1已用作小鼠中的赖氨酸特异性脱甲基酶 1（LSD1）抑制剂，用于研究败血症诱导的死亡率。它还被用作抑制剂，用于研究苯乙肼激活人类免疫缺陷病毒（HIV）潜伏期是否由 LSD1 引起。
生化/生理作用
GSK-LSD1 是赖氨酸特异性脱甲基酶 1 的有效选择性抑制剂。
GSK-LSD1 是赖氨酸特异性脱甲基酶 1（LSD1）的有效选择性抑制剂。GSK-LSD1 通过改变基因表达模式有效抑制不同癌细胞系的增殖。有关完整特征描述的详细信息，请访问 Structural Genomics Consortium（SGC）网站上的 GSK-LSD1 探针目录。
要了解用于表观遗传目标的其他 SGC 化学探针，请访问 sigma.com/sgc
要了解用于表观遗传目标的其他 SGC 化学探针，请访问 sigma.com/sgc
特点和优势
GSK-LSD1 是一种表观遗传化学探针，是与 Structural Genomics Consortium (SGC) 合作研发的。想要了解更多信息并查看其他SGC表观遗传探针，请访问sigma.com/SGC。
这种化合物是基因调控研究的特色产品。点击此处发现更多特色基因调控产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。
储存分类代码
11 - Combustible Solids
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
Bastian Ramms et al.
Diabetes, 71(12), 2513-2529 (2022-09-27)
The transition from lean to obese states involves systemic metabolic remodeling that impacts insulin sensitivity, lipid partitioning, inflammation, and glycemic control. Here, we have taken a pharmacological approach to test the role of a nutrient-regulated chromatin modifier, lysine-specific demethylase (LSD1)
HIV-1 infection of microglial cells in a reconstituted humanized mouse model and identification of compounds that selectively reverse HIV latency
Llewellyn GN, et al.
Journal of Neurovirology, 1-12 (2017)
PKCα-LSD1-NF-κB-Signaling Cascade Is Crucial for Epigenetic Control of the Inflammatory Response
Kim D, et al.
Molecular Cell, 69(3), 398-411 (2018)
Cavan P Bailey et al.
Frontiers in immunology, 11, 2196-2196 (2020-10-13)
Cell therapies such as chimeric-antigen receptor (CAR) T-cells and NK cells are cutting-edge methods for treating cancer and other diseases. There is high interest in optimizing drug treatment regimens to best work together with emerging cell therapies, such as targeting
Carl M Gay et al.
Cancer cell, 39(3), 346-360 (2021-01-23)
Despite molecular and clinical heterogeneity, small cell lung cancer (SCLC) is treated as a single entity with predictably poor results. Using tumor expression data and non-negative matrix factorization, we identify four SCLC subtypes defined largely by differential expression of transcription
商品
We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持